Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience

Kelsey Klute, Ersilia M. DeFilippis, Kelissa Shillingford, John Chapin, Maria T. DeSancho

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

Splanchnic vein thrombosis (SVT) is an uncommon form of venous thrombosis. Management can be challenging due to underlying conditions, increased bleeding risk, and lack of evidence from clinical trials. We sought to characterize the presentation and management of patients with SVT at a large tertiary hospital. A total of 43 patients’ electronic medical records were reviewed. Median age at diagnosis was 43 (18–71). Sixteen patients had isolated portal vein thrombosis (37.2 %), and 16 (37.2 %) had thrombosis involving multiple splanchnic veins. Abdominal pain was the most common clinical presentation (67.4 %). Thrombophilia was present in 18 patients (41.9 %), nine had underlying liver disease (20.9 %) and seven had inflammatory bowel disease (16.3 %). Thirty-nine (90.7 %) patients were treated with anticoagulation, and 11(25.6 %) of these patients underwent interventional procedures. Thirty (69.8 %) patients remained on indefinite anticoagulation. Results of follow-up imaging at least 1 month after diagnosis were available for 29 patients; imaging showed chronic, stable thrombosis in 14 patients (48.3 %), resolution of thrombosis in 13 patients (44.8 %) and asymptomatic progression in two patients (6.9 %). Recurrent thrombosis occurred in four patients (9.3 %). Major bleeding occurred in eight patients who received anticoagulation (18.6 %), including fatal subdural hematoma in one patient. In this cohort of patients managed by hematologists and gastroenterologists, the majority of patients were treated with anticoagulation. Interventional procedures were higher than in previously reported series. Our study strongly supports the interdisciplinary management of splanchnic venous thrombosis.

Original languageEnglish (US)
Pages (from-to)267-271
Number of pages5
JournalJournal of Thrombosis and Thrombolysis
Volume42
Issue number2
DOIs
StatePublished - Aug 1 2016

Fingerprint

Viscera
Veins
Thrombosis
Venous Thrombosis
Hemorrhage
Subdural Hematoma
Thrombophilia
Electronic Health Records
Portal Vein
Inflammatory Bowel Diseases
Tertiary Care Centers

Keywords

  • Outcome
  • Registries
  • Splanchnic circulation
  • Venous thrombosis

ASJC Scopus subject areas

  • Hematology
  • Cardiology and Cardiovascular Medicine

Cite this

Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis : a single-center experience. / Klute, Kelsey; DeFilippis, Ersilia M.; Shillingford, Kelissa; Chapin, John; DeSancho, Maria T.

In: Journal of Thrombosis and Thrombolysis, Vol. 42, No. 2, 01.08.2016, p. 267-271.

Research output: Contribution to journalArticle

Klute, Kelsey ; DeFilippis, Ersilia M. ; Shillingford, Kelissa ; Chapin, John ; DeSancho, Maria T. / Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis : a single-center experience. In: Journal of Thrombosis and Thrombolysis. 2016 ; Vol. 42, No. 2. pp. 267-271.
@article{5dce0665fab44e849e42066ed5d01e52,
title = "Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis: a single-center experience",
abstract = "Splanchnic vein thrombosis (SVT) is an uncommon form of venous thrombosis. Management can be challenging due to underlying conditions, increased bleeding risk, and lack of evidence from clinical trials. We sought to characterize the presentation and management of patients with SVT at a large tertiary hospital. A total of 43 patients’ electronic medical records were reviewed. Median age at diagnosis was 43 (18–71). Sixteen patients had isolated portal vein thrombosis (37.2 {\%}), and 16 (37.2 {\%}) had thrombosis involving multiple splanchnic veins. Abdominal pain was the most common clinical presentation (67.4 {\%}). Thrombophilia was present in 18 patients (41.9 {\%}), nine had underlying liver disease (20.9 {\%}) and seven had inflammatory bowel disease (16.3 {\%}). Thirty-nine (90.7 {\%}) patients were treated with anticoagulation, and 11(25.6 {\%}) of these patients underwent interventional procedures. Thirty (69.8 {\%}) patients remained on indefinite anticoagulation. Results of follow-up imaging at least 1 month after diagnosis were available for 29 patients; imaging showed chronic, stable thrombosis in 14 patients (48.3 {\%}), resolution of thrombosis in 13 patients (44.8 {\%}) and asymptomatic progression in two patients (6.9 {\%}). Recurrent thrombosis occurred in four patients (9.3 {\%}). Major bleeding occurred in eight patients who received anticoagulation (18.6 {\%}), including fatal subdural hematoma in one patient. In this cohort of patients managed by hematologists and gastroenterologists, the majority of patients were treated with anticoagulation. Interventional procedures were higher than in previously reported series. Our study strongly supports the interdisciplinary management of splanchnic venous thrombosis.",
keywords = "Outcome, Registries, Splanchnic circulation, Venous thrombosis",
author = "Kelsey Klute and DeFilippis, {Ersilia M.} and Kelissa Shillingford and John Chapin and DeSancho, {Maria T.}",
year = "2016",
month = "8",
day = "1",
doi = "10.1007/s11239-016-1337-4",
language = "English (US)",
volume = "42",
pages = "267--271",
journal = "Journal of Thrombosis and Thrombolysis",
issn = "0929-5305",
publisher = "Springer Netherlands",
number = "2",

}

TY - JOUR

T1 - Clinical presentations, risk factors, treatment and outcomes in patients with splanchnic vein thrombosis

T2 - a single-center experience

AU - Klute, Kelsey

AU - DeFilippis, Ersilia M.

AU - Shillingford, Kelissa

AU - Chapin, John

AU - DeSancho, Maria T.

PY - 2016/8/1

Y1 - 2016/8/1

N2 - Splanchnic vein thrombosis (SVT) is an uncommon form of venous thrombosis. Management can be challenging due to underlying conditions, increased bleeding risk, and lack of evidence from clinical trials. We sought to characterize the presentation and management of patients with SVT at a large tertiary hospital. A total of 43 patients’ electronic medical records were reviewed. Median age at diagnosis was 43 (18–71). Sixteen patients had isolated portal vein thrombosis (37.2 %), and 16 (37.2 %) had thrombosis involving multiple splanchnic veins. Abdominal pain was the most common clinical presentation (67.4 %). Thrombophilia was present in 18 patients (41.9 %), nine had underlying liver disease (20.9 %) and seven had inflammatory bowel disease (16.3 %). Thirty-nine (90.7 %) patients were treated with anticoagulation, and 11(25.6 %) of these patients underwent interventional procedures. Thirty (69.8 %) patients remained on indefinite anticoagulation. Results of follow-up imaging at least 1 month after diagnosis were available for 29 patients; imaging showed chronic, stable thrombosis in 14 patients (48.3 %), resolution of thrombosis in 13 patients (44.8 %) and asymptomatic progression in two patients (6.9 %). Recurrent thrombosis occurred in four patients (9.3 %). Major bleeding occurred in eight patients who received anticoagulation (18.6 %), including fatal subdural hematoma in one patient. In this cohort of patients managed by hematologists and gastroenterologists, the majority of patients were treated with anticoagulation. Interventional procedures were higher than in previously reported series. Our study strongly supports the interdisciplinary management of splanchnic venous thrombosis.

AB - Splanchnic vein thrombosis (SVT) is an uncommon form of venous thrombosis. Management can be challenging due to underlying conditions, increased bleeding risk, and lack of evidence from clinical trials. We sought to characterize the presentation and management of patients with SVT at a large tertiary hospital. A total of 43 patients’ electronic medical records were reviewed. Median age at diagnosis was 43 (18–71). Sixteen patients had isolated portal vein thrombosis (37.2 %), and 16 (37.2 %) had thrombosis involving multiple splanchnic veins. Abdominal pain was the most common clinical presentation (67.4 %). Thrombophilia was present in 18 patients (41.9 %), nine had underlying liver disease (20.9 %) and seven had inflammatory bowel disease (16.3 %). Thirty-nine (90.7 %) patients were treated with anticoagulation, and 11(25.6 %) of these patients underwent interventional procedures. Thirty (69.8 %) patients remained on indefinite anticoagulation. Results of follow-up imaging at least 1 month after diagnosis were available for 29 patients; imaging showed chronic, stable thrombosis in 14 patients (48.3 %), resolution of thrombosis in 13 patients (44.8 %) and asymptomatic progression in two patients (6.9 %). Recurrent thrombosis occurred in four patients (9.3 %). Major bleeding occurred in eight patients who received anticoagulation (18.6 %), including fatal subdural hematoma in one patient. In this cohort of patients managed by hematologists and gastroenterologists, the majority of patients were treated with anticoagulation. Interventional procedures were higher than in previously reported series. Our study strongly supports the interdisciplinary management of splanchnic venous thrombosis.

KW - Outcome

KW - Registries

KW - Splanchnic circulation

KW - Venous thrombosis

UR - http://www.scopus.com/inward/record.url?scp=84975609384&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84975609384&partnerID=8YFLogxK

U2 - 10.1007/s11239-016-1337-4

DO - 10.1007/s11239-016-1337-4

M3 - Article

C2 - 26831481

AN - SCOPUS:84975609384

VL - 42

SP - 267

EP - 271

JO - Journal of Thrombosis and Thrombolysis

JF - Journal of Thrombosis and Thrombolysis

SN - 0929-5305

IS - 2

ER -